Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ESLA
#3530
Estrella Immunopharma, Inc. Common Stock
1.2
2
+0.83%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+0.83%
Changement Mensuel
+10.91%
Evolution sur 6 mois
+29.79%
Changement Annuel
+25.77%
Clôture Précédente
1.2
1
Open
1.2
2
Bid
Ask
Low
1.2
2
High
1.2
2
Volume
1
Marchés
Actions des Marchés US
Soins de Santé
ESLA
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q1, 25
Q2, 25
Q3, 25
TTM
Cash from operating activities
-465.98 K
-414.88 K
-727.33 K
-3.83 M
Cash from investing activities
—
—
—
—
Cash from financing activities
-29.46 K
1.31 M
1.04 M
2.17 M
Free cash flow
-465.98 K
-414.88 K
-727.33 K
-3.83 M
Nouvelles
Estrella relata taxa de resposta completa de 100% em ensaio de linfoma
Estrella reports 100% complete response rate in lymphoma trial
Estrella apresentará dados da fase 1 sobre terapia celular direcionada a CD19
Estrella to present phase 1 data on CD19-targeted cell therapy
Estrella Immunopharma recebe notificação da Nasdaq por atraso em assembleia anual
Estrella Immunopharma receives Nasdaq notice for delayed annual meeting
Estrella Immunopharma conclui oferta direta registrada de US$ 8 milhões
Estrella Immunopharma closes $8 million registered direct offering
Ações da Estrella Immunopharma caem após anúncio de oferta de US$ 8 milhões
Estrella Immunopharma stock falls after announcing $8 million offering
Estrella Immunopharma capta US$ 8 milhões por meio de oferta registrada
Estrella Immunopharma raises $8 million through registered offering